Medical and Pharmaceutical Guardant Health gets oncology innovation accolade at Healthcare Asia Medtech Awards 2026 The company was recognized for its multi-cancer detection test Rowan Dunne4 days ago
AI and Autonomy Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI The companies plan to build proof-of-concept models that predict how patients will respond to treatment Joseph MortonMarch 27, 2026
Medical and Pharmaceutical Guardant Health launches multi-cancer blood test in Asia through Manulife partnership Cancer remains a leading cause of death across Asia, driving demand for early screening tools Joseph MortonMarch 18, 2026
Medical and Pharmaceutical bioAffinity launches 2,000-patient study for noninvasive lung cancer test The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes Joseph MortonMarch 11, 2026
Medical and Pharmaceutical Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test The ctDNA blood draw is known for its ultrasensitive detection capabilities Rowan DunneFebruary 10, 2026
Medical and Pharmaceutical Olympus rolls out advanced SecureFlex EUS biopsy needle in U.S. market The SecureFlex needle supports endoscopic ultrasound-guided fine needle biopsy Joseph MortonJanuary 28, 2026
AI and Autonomy BioMark earns peer-reviewed validation for AI-driven lung cancer detection model BioMark’s accepted paper describes a predictive model built on metabolomic pathway data rather than single biomarkers Joseph MortonJanuary 21, 2026
Medical and Pharmaceutical Imperial College and Pancreatic Cancer UK begin 6,000 patient breath test study Pancreatic cancer remains one of the deadliest cancers in the UK Joseph MortonDecember 9, 2025
Medical and Pharmaceutical BioMark Diagnostics receives Innovation Award for lung cancer screening project It acknowledges the company’s development of an efficacious blood biopsy Rowan DunneDecember 3, 2025
Medical and Pharmaceutical BioMark Diagnostics ships liquid biopsy tech to Germany for 10,000-person lung cancer study 'HANSE' is the nation's largest lung cancer trial of all time Rowan DunneNovember 13, 2025